1 |
Ediriweera MK, Jayasena S. The Role of Reprogrammed Glucose Metabolism in Cancer. Metabolites 2023;13:345. [DOI: 10.3390/metabo13030345] [Reference Citation Analysis]
|
2 |
Liang Y, Rao Z, Du D, Wang Y, Fang T. Butyrate prevents the migration and invasion, and aerobic glycolysis in gastric cancer via inhibiting Wnt/β-catenin/c-Myc signaling. Drug Dev Res 2023. [PMID: 36782390 DOI: 10.1002/ddr.22043] [Reference Citation Analysis]
|
3 |
Xu Y, Hao X, Ren Y, Xu Q, Liu X, Song S, Wang Y. Research progress of abnormal lactate metabolism and lactate modification in immunotherapy of hepatocellular carcinoma. Front Oncol 2022;12:1063423. [PMID: 36686771 DOI: 10.3389/fonc.2022.1063423] [Reference Citation Analysis]
|
4 |
Chuanbing Z, Zhengle Z, Ruili D, Kongfan Z, Jing T. Genes Modulating Butyrate Metabolism for Assessing Clinical Prognosis and Responses to Systematic Therapies in Hepatocellular Carcinoma. Biomolecules 2022;13. [PMID: 36671437 DOI: 10.3390/biom13010052] [Reference Citation Analysis]
|
5 |
Li R, Mei S, Ding Q, Wang Q, Yu L, Zi F. A pan-cancer analysis of the role of hexokinase II (HK2) in human tumors. Sci Rep 2022;12:18807. [PMID: 36335239 DOI: 10.1038/s41598-022-23598-8] [Reference Citation Analysis]
|
6 |
Wang X, Wu L, Ji H, Liu Q, Deng S, Dou Q, Ai L, Pan W, Zhang H. A novel cuproptosis-related prognostic signature and potential value in HCC immunotherapy. Front Mol Biosci 2022;9:1001788. [DOI: 10.3389/fmolb.2022.1001788] [Reference Citation Analysis]
|
7 |
Deng S, Chen B, Huo J, Liu X. Therapeutic potential of NR4A1 in cancer: Focus on metabolism. Front Oncol 2022;12:972984. [DOI: 10.3389/fonc.2022.972984] [Reference Citation Analysis]
|